hyaluronoglucosaminidase has been researched along with Epithelial Ovarian Cancer in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Götte, M; Győrffy, B; Kiesel, L; Parnigoni, A; Passi, A; Riecks, J; Vigetti, D | 1 |
| Chen, S; Liu, Y; Shen, F; Sheng, XJ; Zhao, Y; Zong, ZH | 1 |
| Carmona, E; Edjekouane, L; Mes-Masson, AM; Meunier, L; Provencher, DM; Tremblay, A; Yoffou, PH | 1 |
3 other study(ies) available for hyaluronoglucosaminidase and Epithelial Ovarian Cancer
| Article | Year |
|---|---|
The hyaluronan-related genes HAS2, HYAL1-4, PH20 and HYALP1 are associated with prognosis, cell viability and spheroid formation capacity in ovarian cancer.
Topics: Carcinoma, Ovarian Epithelial; Cell Survival; Cisplatin; Female; Glucuronosyltransferase; Humans; Hyaluronan Synthases; Hyaluronic Acid; Hyaluronoglucosaminidase; Ovarian Neoplasms; Paclitaxel; Prognosis; RNA, Messenger; RNA, Small Interfering | 2022 |
CEMIP promotes ovarian cancer development and progression via the PI3K/AKT signaling pathway.
Topics: Apoptosis; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Progression; Female; Gene Expression Regulation, Neoplastic; Humans; Hyaluronoglucosaminidase; Ovarian Neoplasms; Phosphatidylinositol 3-Kinases; Proteins; Proto-Oncogene Proteins c-akt; Signal Transduction | 2019 |
Subtype specific elevated expression of hyaluronidase-1 (HYAL-1) in epithelial ovarian cancer.
Topics: Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Biomarkers, Tumor; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Culture Media, Conditioned; Estrogen Receptor alpha; Female; Gene Expression Regulation, Neoplastic; Humans; Hyaluronoglucosaminidase; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Receptors, Progesterone | 2011 |